Non-small-cell lung cancer – Biasly

Understand the bias, discover the truth in your news.

Non-small-cell lung cancer Follow

default thumbnail

Preclinical development

Olema Oncology to Present Preclinical Data for OP-3136, a Potent KAT6 Inhibitor, Demonstrating Anti-Tumor Activity in Multiple Solid Tumor Models a...

Taiwan News
Mar 25, 2025

Center

Olema Oncology to Present Preclinical Data for OP-3136, a Potent KAT6 Inhibitor, Demonstrating Anti-Tumor Activity in Multiple Solid Tumor Models at the 2025 AACR Annual Meeting - Olema Pharmaceuticals (NASDAQ:OLMA)

Preclinical development

Olema Oncology to Present Preclinical Data for OP-3136, a Potent KAT6 Inhibitor, Demonstrating Anti-Tumor Activity in Multiple Solid Tumor Models a...

Benzinga
Mar 25, 2025

Center

BioAtla Announces Two Poster Presentations at Upcoming Medical Meetings - BioAtla (NASDAQ:BCAB)

Non-small-cell lung cancer

BioAtla Announces Two Poster Presentations at Upcoming Medical Meetings - BioAtla (NASDAQ:BCAB)

Benzinga
Mar 20, 2025

Center

3 Stocks That Could Be Monster Winners in 2025 | The Motley Fool

Novo Nordisk

3 Stocks That Could Be Monster Winners in 2025 | The Motley Fool

The Motley Fool
Dec 29, 2024

Center

EMA CHMP recommends AstraZeneca's Tagrisso for lung cancer

Combination therapy

EMA CHMP recommends AstraZeneca's Tagrisso for lung cancer

Yahoo! Finance
Jun 04, 2024

Center